Screening for subclinical coronary and myocardial disease in subjects with diabetes and metabolic syndrome

被引：0
|
作者：
Wong, C. [1 ]
Leano, R. [1 ]
Haluska, B. [1 ]
Marwick, T. H. [1 ]
机构：
[1] Univ Queensland, Sch Med, Brisbane, Qld, Australia
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：527 / 527
页数：1
相关论文
共 50 条
  • [21] Coronary Artery Calcium Screening in Persons with Metabolic Syndrome and Diabetes: Implications for Prevention
    Tehrani, David M.
    Malik, Shaista
    Wong, Nathan D.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2013, 11 (03) : 143 - 148
  • [22] Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome
    Burggraaf, Benjamin
    van Breukelen-van der Stoep, Deborah F.
    de Vries, Marijke A.
    Klop, Boudewijn
    van Zeben, Jende
    van de Geijn, Gert-Jan M.
    van der Meulen, Noelle
    Birnie, Erwin
    Prinzen, Lenneke
    Cabezas, Manuel Castro
    ATHEROSCLEROSIS, 2018, 271 : 84 - 91
  • [23] Progression of Subclinical Atherosclerosis in Subjects With Rheumatoid Arthritis and Metabolic Syndrome
    Burggraaf, Benjamin
    Van Breukelen-van der Stoep, Deborah F.
    de Vries, Marijke A.
    Klop, Boudewijn
    van Zeben, Jende
    van de Geijn, Gert-Jan M.
    van der Meulen, Noelle
    Prinzen, Lenneke
    Cabezas, Manuel Castro
    CIRCULATION, 2017, 136
  • [24] Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome
    Izar, Maria C.
    Fonseca, Henrique A.
    Pinheiro, Luiz F.
    Monteiro, Carlos M.
    Povoa, Rui M.
    Monteiro, Andrea M.
    Figueiredo-Neto, Antonio M.
    Gidlund, Magnus A.
    Fonseca, Francisco A.
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (01): : 32 - 39
  • [25] Metabolic syndrome improves the prediction of coronary heart disease mortality in diabetes
    Langenberg, C
    Bergstrom, J
    Von Mühlen, D
    Barrett-Connor, E
    CIRCULATION, 2006, 113 (08) : E343 - E343
  • [26] Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
    Fisman, Enrique Z.
    Tenenbaum, Alexander
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [27] Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome
    Labazi, Hicham
    Trask, Aaron J.
    PHARMACOLOGICAL RESEARCH, 2017, 123 : 114 - 121
  • [28] Metabolic Syndrome, Diabetes, and Coronary Artery Disease: a Very Common Association
    Vegas-Valle, Jose M.
    Garcia-Ruiz, Jose M.
    Hernandez-Martin, Ernesto
    de la Hera, Jesus M.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2012, 65 (01): : 108 - 109
  • [29] Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
    Enrique Z Fisman
    Alexander Tenenbaum
    Cardiovascular Diabetology, 13
  • [30] Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis
    Wong, ND
    Rozanski, A
    Gransar, H
    Miranda-Peats, R
    Kang, XP
    Hayes, S
    Shaw, L
    Friedman, J
    Polk, D
    Berman, DS
    DIABETES CARE, 2005, 28 (06) : 1445 - 1450
12345